Featured Research

from universities, journals, and other organizations

Surgical Technique Enables Extirpation Of Benign Tumors Of The Pancreas

Date:
February 12, 2009
Source:
Basque Research
Summary:
A laparoscopic surgical technique enables extirpation of pancreatic tumors that are benign or of scant, highly localized malignant potential and that preserves the function of the organ to the maximum, at the same time significantly reducing the number of possible complications and the period of hospitalization.

A laparoscopic surgical technique enables extirpation of pancreatic tumours that are benign or of scant, highly localised malignant potential and that preserves the function of the organ to the maximum, at the same time significantly reducing the number of possible complications and the period of hospitalisation.

This minimally invasive procedure, pioneering in Spain, has been developed by a team of surgeons at the University Hospital of Navarra, which brings together the greatest experience worldwide in this technique.

The results obtained in patients were recently published in the specialised surgery journal of greatest international impact, Annals of Surgery. It is the highest number of patients operated on using laparoscopic central pancreatectomy and that has been published in scientific literature worldwide. The specialists who took part in the study and who undertook the surgical technique are Doctors Fernando Pardo, Fernando Rotellar and Custodia Montiel, surgeons at the University Hospital of Navarra

As Doctor Pardo, Director of the Hepatobiliopancreatic Surgery service states, this technique has been recognised as a feasible procedure that reduces complications and hospitalisation periods, in a highly specific pancreatic pathology. The main achievement is having managed to devise a laparoscopic surgery technique for operations which to date has only been possible through open surgery. This new laparoscopic method is much less invasive and enables a large part of the gland to be conserved, and thus avoids the appearance of post-operative diabetes.

Complex technique - excellent results

The results of the laparoscopic central pancreatectomy have been excellent, according to Doctor Rotellar, and can even exceed those achieved by open surgery. According to this specialist, the laparoscopic technique reduces complications compared to open surgery. The period of hospitalisation is reduced from the average of ten days with the conventional procedure to four days with laparoscopy. The much lower rates for side effects also bear on reduced hospitalisation periods.

The tumours that these operations target are mainly neuroendocrine or cystic tumours of the pancreas that are benign or of low malignant potential. These lesions are diagnosed with greater frequency amongst young women, with an average age of 30, states Doctor Rotellar. Thus, the principal goal of this procedure is to obtain the optimum precision surgery in such a way that we are able to preserve the pancreas to the maximum. This is why laparoscopic central pancreatectomy is not suitable for tumours of poorer prognosis where it is paramount to operate radically in order to avoid a future regeneration of the tumour.

The importance of this surgical technique lies in managing to extirpate the minimum portion possible of the pancreas and, consequently, avoid the risk of the patient developing an intolerance to glucose or diabetes, besides any digestive problems that may arise from the lack of pancreatic enzymes, pointed out Doctor Pardo.

The surgeon also stated that laparoscopic central pancreatectomy is a pioneering technique, given its complex nature (after extirpating a portion of the pancreas, an anastomosis or union of the pancreatic duct with the intestine is carried out by laparoscopy). This joining to the intestine is necessary for the pancreas to be able to secrete its juices into it and, thus, it is a highly delicate operation.


Story Source:

The above story is based on materials provided by Basque Research. Note: Materials may be edited for content and length.


Cite This Page:

Basque Research. "Surgical Technique Enables Extirpation Of Benign Tumors Of The Pancreas." ScienceDaily. ScienceDaily, 12 February 2009. <www.sciencedaily.com/releases/2009/02/090203110449.htm>.
Basque Research. (2009, February 12). Surgical Technique Enables Extirpation Of Benign Tumors Of The Pancreas. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/02/090203110449.htm
Basque Research. "Surgical Technique Enables Extirpation Of Benign Tumors Of The Pancreas." ScienceDaily. www.sciencedaily.com/releases/2009/02/090203110449.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins